22 | PhosphatidylserinesIBA
01/2017
-
11/2002 |
15 | Monoclonal AntibodiesIBA
01/2016
-
01/2002 |
11 | Phospholipids (Phosphatides)FDA LinkGeneric
01/2011
-
11/2002 |
10 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2016
-
01/2002 |
9 | bavituximabIBA
01/2017
-
09/2007 |
7 | AntibodiesIBA
11/2012
-
03/2003 |
6 | Proteins (Proteins, Gene)FDA Link
03/2012
-
01/2004 |
4 | Docetaxel (Taxotere)FDA Link
05/2016
-
05/2005 |
4 | Oxygen (Dioxygen)IBA
04/2012
-
01/2002 |
4 | Phenobarbital (Luminal)FDA Link
12/2011
-
09/2007 |
4 | Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2011
-
03/2003 |
4 | LigandsIBA
06/2004
-
10/2002 |
3 | Biomarkers (Surrogate Marker)IBA
05/2014
-
06/2004 |
3 | Gelonium multiflorum GEL proteinIBA
08/2011
-
05/2005 |
3 | Therapeutic UsesIBA
01/2011
-
01/2002 |
3 | Peptides (Polypeptides)IBA
04/2009
-
03/2003 |
2 | Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
05/2016
-
10/2005 |
2 | Antiphospholipid AntibodiesIBA
01/2016
-
01/2011 |
2 | IsotopesIBA
01/2013
-
03/2008 |
2 | AntigensIBA
12/2011
-
09/2004 |
2 | Reactive Oxygen Species (Oxygen Radicals)IBA
04/2011
-
11/2002 |
2 | beta 2-Glycoprotein I (Apolipoprotein H)IBA
11/2009
-
02/2005 |
2 | Blood Proteins (Serum Proteins)IBA
10/2006
-
02/2005 |
2 | DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
10/2005
-
10/2004 |
2 | Angiogenesis InhibitorsIBA
01/2004
-
03/2003 |
2 | Immunoglobulin G (IgG)IBA
07/2003
-
01/2002 |
2 | CytokinesIBA
12/2002
-
11/2002 |
2 | ThrombinFDA Link
12/2002
-
11/2002 |
1 | Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
12/2016 |
1 | Sorafenib (BAY 43-9006)FDA Link
12/2016 |
1 | Granulocyte Colony-Stimulating Factor (G-CSF)IBA
05/2016 |
1 | Doxorubicin (Adriamycin)FDA LinkGeneric
05/2016 |
1 | Thromboplastin (Tissue Factor)IBA
05/2016 |
1 | Colony-Stimulating Factors (Colony Stimulating Factor)IBA
05/2016 |
1 | low density lipoprotein receptor-related protein 8IBA
01/2016 |
1 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2015 |
1 | Chelating AgentsIBA
01/2015 |
1 | Acetates (Acetic Acid Esters)FDA Link
05/2014 |
1 | Aligeron (AS 2)IBA
05/2014 |
1 | Contrast MediaIBA
05/2014 |
1 | Immunoglobulin FragmentsIBA
01/2013 |
1 | Iodine-124IBA
01/2013 |
1 | Cisplatin (Platino)FDA LinkGeneric
04/2012 |
1 | Fibroblast Growth Factor 1 (FGF-1)IBA
03/2012 |
1 | VaccinesIBA
06/2011 |
1 | Interleukin-2 (IL2)IBA
06/2011 |
1 | duramycinIBA
04/2011 |
1 | phosphatidylethanolamineIBA
04/2011 |
1 | Prothrombin (Factor II)IBA
03/2011 |
1 | Glycoproteins (Glycoprotein)IBA
01/2011 |
1 | 2,2- bis(hydroxymethyl)- 1- azabicyclo(2,2,2,)octan- 3- oneIBA
01/2011 |
1 | Chemokine CCL3IBA
04/2010 |
1 | Chemokine CCL4IBA
04/2010 |
1 | Neoplasm Antigens (Tumor Antigens)IBA
11/2009 |
1 | Apoptosis Regulatory ProteinsIBA
04/2009 |
1 | Biological Warfare AgentsIBA
12/2008 |
1 | ArsenicIBA
03/2008 |
1 | GemcitabineFDA Link
05/2006 |
1 | Biotin (Vitamin H)FDA Link
10/2005 |
1 | Immunoglobulins (Immunoglobulin)IBA
02/2005 |
1 | Sirolimus (Rapamycin)FDA Link
10/2004 |
1 | Bromodeoxyuridine (BrdU)IBA
10/2004 |
1 | Immunotoxins (Immunotoxin)IBA
09/2004 |
1 | Immunoconjugates (Immunoconjugate)IBA
09/2004 |